Huntingdon/Harlan to receive $125 million funding
UK contract research company Huntingdon Life Sciences and US contract research firm Harlan Laboratories are to receive up to $125 million in a minority equity financing by a group of institutional investors. The investment can be used to fund future growth initiatives, the companies say. Huntingdon acquired Harlan last year and the combined company formed after the integration is to be named Envigo. The combined organisation has 3,800 people and annual sales of some $500 million. “This equity investment of up to $125 million validates the success of that integration and further strengthens the company’s balance sheet to pursue additional organic and strategic investments,” says chief executive officer Brian Cass.